What's in a name? A lot if you ask us. Introducing: Precision AQ. It's a nod to our mission, empowering access to life-changing medicine for all, but also our approach. IQ + EQ = Precision Access Quotient (AQ). We've fused together the science 🧪 (IQ) and empathy ❤️ (EQ) of nine diverse organizations into one brand to offer greater access to the services, data, expertise, and scale needed to navigate the therapy-to-patient journey. Learn more about our new blueprint for access: https://lnkd.in/gvB9eCJh
Precision AQ
Business Consulting and Services
New York, NY 19,586 followers
Empowering access to life-changing medicines for all.
About us
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life changing medicines. Our global offerings include: • Commercial Consulting • HEOR • Market Access Marketing • Medical Communications • Advertising, Branding, and PR • Investor Relations and External Communications • Data and Product solutions Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
- Website
-
http://www.precisionaq.com
External link for Precision AQ
- Industry
- Business Consulting and Services
- Company size
- 1,001-5,000 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Specialties
- Market access, HEOR, Medical communications, Payer marketing, Pharma advertising, Advertising & PR, Investor Relations & External Communications, Omnichannel Solutions, Payer, Provider, Patient Data Solutions, Pharma commercialization research and strategy, Patient insights, and Learning & development
Locations
-
Primary
New York, NY, US
-
London, GB
-
Brussels, BE
Employees at Precision AQ
Updates
-
The landscape of drug pricing is shifting dramatically, and understanding these changes is key to maintaining access to life-changing medicines. The Inflation Reduction Act (IRA) introduces new dynamics that can reshape your approach. Our white paper, “Navigating the IRA: Key Impacts and Strategies for Market Readiness,” provides essential insights and expert guidance to help you navigate the legislation effectively. Download our insights: https://lnkd.in/eKFy9Mra #InflationReductionAct #IRA #marketaccess #drugpricing #reimbursement #pricingstrategy #innovation #healthcarereform
-
Embracing patient-centric healthcare means more than just listening—it's about truly integrating patient experiences. The 2024 Good Patient Partnership Guide provides practical insights and inspiring stories to help overcome challenges and keep patients at the heart of your efforts. Dive into the Guide: https://hubs.ly/Q02KypTJ0 #patientcentricity #healthcare #patientadvocacy #patientinformation #patientvoice #patientpartners #patientexperience #pharmaceuticalindustry
-
Struggling to diversify your clinical research? A solution to this common clinical trial obstacle could be involving payers from the onset of research design. Doug Fulling, President and Andrew Cournoyer, SVP, Director - Access Experience Team explain why close collaboration between payers and clinical teams could enable greater access to key therapies for patients in a short video for AJMC - The American Journal of Managed Care. Watch now: https://lnkd.in/eDGJxVUq #HealthcareInnovation #ClinicalResearch #DiversityinTrials
-
The FDA has recently approved two transformative therapies, offering life-changing medicine to 100,000 individuals in the U.S. affected by sickle cell disease. Our leaders, Philip Cyr, SVP, and Erin Lopata, VP, Director - Access Experience Team, collaborated with Joe DePinto, Head of Cell, Gene, and Advanced Therapies at McKesson, to share their insights with CGTLive on the innovative CMS CGT Access Model. This model is set to revolutionize patient access, enhance health outcomes, and manage healthcare costs more effectively. Dive deeper into the model and its impact: https://lnkd.in/ee6U-pmN #HealthcareInnovation #SickleCellDisease #PatientCare #FDAApproval #cellandgenetherapy
-
Early collaboration between payers and clinical trial teams could be the key to solving access challenges, says Andrew Cournoyer, SVP and Director of our Access Experience Team. From making the introduction of new technologies into the space less time consuming to helping teams prepare for Medicare negotiations, he explains why breaking silos can lead to greater therapeutic access for patients in AJMC - The American Journal of Managed Care. Watch now: https://lnkd.in/geZ_HG43 #MarketAccess #HealthcareStrategy #PayerEngagement
-
Imagine a world where patient partnerships drive every breakthrough. Our 2024 Good Patient Partnership Guide explores this vision with insightful stories and practical strategies. Dive into the experience shared by Trishna Bharadia, BA(hons), MFPM(Hon), Patient Engagement Consultant and Health Advocate, and understand how patient empowerment can lead to transformative outcomes: https://lnkd.in/eAEqVRMT
-
ASCO 2024 marked a celebration of ground breaking innovations in oncology while recognizing the ongoing journey toward improving patient care. Dr. Lynn M. Schuchter's inspiring address reminded us that the true art of cancer care lies in blending scientifiic breakthroughs with compassionate, personalized support. At Precision AQ, we’re dedicated to this vision. Our patient support and insights team identified key themes from the annual meeting that prioritize enhancing the patient experience. Explore the key takeaways and how we can make a difference together: https://lnkd.in/eyqi5fTW #ASCO2024 #CancerCare #PatientExperience #InnovationInOncology
-
Patients are the driving force behind every research breakthrough, every advancement, and every cure. But how often are their voices heard from the start? The 2024 Good Patient Partnership Guide offers inspiring ideas and realistic steps to build a truly patient-first culture. Discover inspiring best practices from the guide: https://hubs.ly/Q02HSD9_0 #patientcentricity #healthcare #patientadvocacy #patientinformation #patientvoice #patientpartners #patientexperience #pharmaceuticalindustry
-
On our radar: The FDA’s proposed changes to biosimilar interchangeability guidance. Can this revised policy enable greater access to medicine for patients? What are the implications for manufacturers? Amy Martin, VP of Access Experience, shares her POV in MMIT (Managed Markets Insight & Technology): https://lnkd.in/eYuwE9iK #Biosimilars #HealthcareInnovation #FDA